Browsing by Subject "Rifampin/pharmacokinetics"

Now showing items 1-1 of 1

Reply to "Adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future"

Requena-Mendez, Ana; Davies, Geraint; Moore, David Alexander James (American Society for Microbiology, 2015)

We thank Sturkenboom et al. for their interest in our study and their comments. The pragmatic study design based on two sampling points, 2 and 6 h after drug intake, reflected the real-world approach taken in this study, ...

Search DSpace